longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

Indivior Pharmaceuticals

INDV

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Current ValuationThe current P/E ratio is 11.88, below the reasonable range, cheaper than 91.57% of the time in the past 1 years, and the industry ranks 16/256, the industry Median -1.38.

11.88xP/E
$35.85Stock price
$3.02Earnings per share
11.88xP/E
Stock price$35.85Earnings per share$3.02

Historical Valuation

P/E ratioTypical rangeMedian
P/E ratio
19.57x
Typical range
17.50x–36.13x

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0295887116

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x20x40x60x80x100x
P/E ratio
Name/Symbol
BMYUSBristol Myers Squibb
13.73x62.25%$127.47B
GSKUSGSK
15.23x14.52%$98.16B
UCBJYUSUCB S.A.
17.37x--$44.23B
HLNUSHaleon
18.27x1.74%$39.64B
OTSKYUSOtsuka Pharmaceutical
14.92x--$38.63B
DSNKYUSDaiichi Sankyo
19.31x--$32.42B
ZTSUSZoetis
10.94x6.81%$28.86B
ALPMYUSAstellas Pharma
11.13x--$25.94B
JAZZUSJazz Pharma
15.98x349.11%$15.03B
OPHLYUSOno Pharmaceutical
14.30x--$6.96B
INDVUSIndivior Pharmaceuticals
11.88x126.83%$4.23B
OGNUSOrganon
17.21x211.11%$3.60B
SNPHYUSSanten Pharmaceutical
14.10x--$3.48B
LQDAUSLiquidia Tech
19.54x458.21%$2.71B
HRMYUSHarmony Biosciences
12.61x45.48%$2.29B
PBHUSPrestige Brands
12.63x7.48%$2.17B
ANIPUSANI Pharma
16.39x51.20%$1.63B
GTBIFUSGreen Thumb Industries Inc.
12.16x--$1.54B
PAHCUSPhibro Animal Health
14.55x26.75%$1.45B
OMERUSOmeros
11.04x1,913.34%$1.38B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.